3940 Trust Way
Hayward, CA 94545
United States
510 780 0819
https://benitec.com
版塊: Healthcare
行業: Biotechnology
全職員工: 16
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Jerel A. Banks M.D., Ph.D. | Executive Chairman & CEO | 848.07k | 無 | 1975 |
Ms. Megan Joan Boston BComm, CA, Dip., GAICD | Executive Director | 439.17k | 無 | 1972 |
Dr. Michael Graham | Head of Discovery & Founding Scientist | 125.22k | 無 | 無 |
Dr. Claudia Kloth | Senior Vice President of Manufacturing | 無 | 無 | 無 |
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
截至 無 止,Benitec Biopharma Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。